Skip to main content
. Author manuscript; available in PMC: 2022 May 7.
Published in final edited form as: Pediatr Neurol. 2019 Dec 3;104:23–29. doi: 10.1016/j.pediatrneurol.2019.11.016

TABLE 5.

Propensity Score Matching

First Treatment N Remission After Treatment (%) P
Initial remission
 Vigabatrin 20 4 (20.0) 0.006*
 ACTH 20 14 (70.0)
 Vigabatrin 23 4 (17.4) 0.004†
 Prednisolone 23 14 (60.9)
 Prednisolone 19 9 (47.4) 0.56†
 ACTH 19 11 (57.9)
Three-month remission
 Vigabatrin 20 9 (45.0) 0.02*
 ACTH 20 17 (85.0)
 Vigabatrin 23 7 (30.4) 0.002†
 Prednisolone 23 18 (78.3)
 Prednisolone 19 15 (79.0) 0.99*
 ACTH 19 14 (73.7)

Matching variables: Age of spasm onset (≤6.25, >6.25, or unknown), spasm onset to first treatment (1 to 30 days, >30 days, or unknown), etiology, prior seizure, abnormal development.

*

Exact McNemar’s test

†

McNemar’s test